Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01CEQ
|
|||
| Former ID |
DIB006540
|
|||
| Drug Name |
CER-227185
|
|||
| Synonyms |
TCTP inhibitor (cancer), Cerenis; Translationally controlled tumor protein inhibitor (acute myeloid leukemia), Cerenis
Click to Show/Hide
|
|||
| Indication | Acute myeloid leukaemia [ICD-11: 2A60] | Discontinued in Phase 1/2 | [1] | |
| Company |
Cerenis
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Translationally-controlled tumor protein (TPT1) | Target Info | Inhibitor | [2] |
| Pathway Interaction Database | PLK1 signaling events | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800026293) | |||
| REF 2 | Clinical pipeline report, company report or official report of Cerep. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.